- Melanoma is now the world’s fastest-growing cancer, claiming one life per hour.
- Melanoma is one of the most genetically complex cancers.
- Melanoma currently costs over $2.65 billion in treatment expenses per year but remains severely underfunded in terms of research.
- Despite advancements in medicine and two newly approved FDA drugs, the melanoma death rate has remained static over the past 30 years while the incidence has tripled.
- Only six FDA-approved therapies for metastatic melanoma exist. Most have long-term benefit for a patient minority, often far below 20%. One has a mean durability of 5.6 months.
- There is a real need for better tools to gauge susceptibility.
- More effective options for prevention, diagnosis, and prognosis are urgently needed if personalized treatment is ever to become a reality.
$ 0 billion
in treatment expenses, but underfunded for research
76,100 New Cases of Melanoma in 2014